Palmitoylcarnitine

Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 1026 references associated with Palmitoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Palmitoylcarnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Insulin Resistance D007333 99 associated lipids
Mitochondrial Diseases D028361 25 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Palmitoylcarnitine

Download all related citations
Per page 10 20 50 100 | Total 302
Authors Title Published Journal PubMed Link
Abdul-Ghani MA et al. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. 2008 Am. J. Physiol. Endocrinol. Metab. pmid:18593850
Ojuka E et al. Measurement of β-oxidation capacity of biological samples by respirometry: a review of principles and substrates. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:26908505
Schooneman MG et al. Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism. 2015 Am. J. Physiol. Endocrinol. Metab. pmid:26037250
Kanaley JA et al. Hyperinsulinemia and skeletal muscle fatty acid trafficking. 2013 Am. J. Physiol. Endocrinol. Metab. pmid:23820622
Jørgensen W et al. Progression of type 2 diabetes in GK rats affects muscle and liver mitochondria differently: pronounced reduction of complex II flux is observed in liver only. 2012 Am. J. Physiol. Endocrinol. Metab. pmid:22713504
Johnson G et al. Influence of intensity of food restriction on skeletal muscle mitochondrial energy metabolism in rats. 2006 Am. J. Physiol. Endocrinol. Metab. pmid:16621897
Pitts BJ and Okhuysen CH Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase. 1984 Am. J. Physiol. pmid:6093598
Xu Z and Rozanski GJ K+ current inhibition by amphiphilic fatty acid metabolites in rat ventricular myocytes. 1998 Am. J. Physiol. pmid:9843728
Kinnula VL and Hassinen I Effect of chronic hypoxia on hepatic triacylglycerol concentration and mitochondrial fatty acid oxidizing capacity in liver and heart. 1978 Acta Physiol. Scand. pmid:626089
Farstad M and Berge R On the capacity of the beta-oxidation of palmitate and palmitoyl-esters in rat liver mitochondria. 1978 Acta Physiol. Scand. pmid:31061